R. Brandely

TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice

J. Marchand, A. van Dorsselaer, J. Strub, 2014, Gut.

Fluorescent Tagged Vaccinia Virus Genome Allows Rapid and Efficient Measurement of Oncolytic Potential and Discovery of Oncolytic Modulators

J. Lagarde, K. Bystricky, J. Foloppe, 2020, Biomedicines.

Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition

L. Zitvogel, J. Marchand, P. Erbs, 2016, Oncoimmunology.

Viral Delivery of IL-7 Is a Potent Immunotherapy Stimulating Innate and Adaptive Immunity and Confers Survival in Sepsis Models

J. Marchand, K. Lélu, Perrine J Martin, 2022, The Journal of Immunology.

Adaptive Immunity and Confers Survival in Immunotherapy Stimulating Innate and Viral Delivery of IL-7 Is a Potent

Marchand, K. Lélu, Perrine J Martin, 2022 .

HIV-1 core proteins expressed from recombinant vaccinia viruses.

M. Kieny, L. Montagnier, J. Lecocq, 1989, AIDS research and human retroviruses.

Yeast Virus-Derived Stimulator of the Innate Immune System Augments the Efficacy of Virus Vector-Based Immunotherapy

G. Hartmann, P. Romby, J. Marchand, 2014, Journal of Virology.